Anlon Healthcare Ltd
Q1 FY27, unaudited
- Revenue
- ₹30.98 Cr
- Profit after tax
- ₹4.80 Cr
As filed with the exchange, standalone basis.
Statement of profit and loss
Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.
| ₹ crore | Q1 FY27 | vs a year ago | FY26 |
|---|---|---|---|
| Revenue from operations | 30.98 | — | 176.50 |
| Other income | 0.06 | — | 0.25 |
| Total income | 31.04 | — | 176.75 |
| Employee benefit expense | 1.52 | — | 5.25 |
| Finance costs | 0.96 | — | 4.35 |
| Depreciation & amortisation | 0.66 | — | 1.36 |
| Total expenses | 25.13 | — | 136.08 |
| Profit before tax | 5.90 | — | 40.68 |
| Tax expense | 1.11 | — | 12.87 |
| Profit after tax | 4.80 | — | 27.81 |
| Total comprehensive income | 4.78 | — | 27.76 |
| Earnings per share, basic | ₹0.09 | ₹5.93 |
|---|---|---|
| Earnings per share, diluted | ₹0.09 | ₹5.93 |
Q1 FY27 — unaudited, from the company’s filing with NSE. Source
FY26 — from the company’s filing with NSE. Source
Why the dash
Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.
Earnings call
Q4 FY26Anlon Healthcare reported FY26 consolidated total income of INR 172.22 crore, up 42.98% year-on-year, with EBITDA up 47.55% and PAT up 41.77%. Q4 FY26 total income was INR 50.90 crore versus INR 48.97 crore a year earlier, while reported PAT of INR 11.07 crore was lower than INR 16.65 crore in the year-ago quarter due to higher operating and development expenses. Management discussed the completed acquisitions of Apiqo Organics and Bizotic Life Science, capacity expansion plans, and provided revenue and margin outlook for FY27 and FY28.
Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary
Filings
12 shown · 54 published by the exchange
17 Aug 2026
Filing14 Aug 2026
14 Aug 2026
14 Aug 2026
Filing13 Aug 2026
13 Aug 2026
13 Aug 2026
13 Aug 2026
12 Aug 2026
Transcript11 Aug 2026
08 Aug 2026
06 Aug 2026
Insider trading
BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.
Page generated from filings held to 17 Aug 2026.